David T. Doherty Sells 13,641 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty sold 13,641 shares of the business’s stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.61, for a total transaction of $349,346.01. Following the transaction, the chief financial officer now directly owns 108,862 shares of the company’s stock, valued at approximately $2,787,955.82. This represents a 11.14 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Surgery Partners Stock Down 0.9 %

SGRY opened at $25.58 on Tuesday. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $35.29. The company has a market capitalization of $3.25 billion, a P/E ratio of -53.29, a P/E/G ratio of 17.77 and a beta of 2.60. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm’s fifty day moving average price is $21.84 and its two-hundred day moving average price is $26.93.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same quarter last year, the firm posted $0.15 earnings per share. Surgery Partners’s revenue was up 14.3% on a year-over-year basis. On average, analysts anticipate that Surgery Partners, Inc. will post 0.71 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Handelsbanken Fonder AB grew its stake in shares of Surgery Partners by 35.1% in the 3rd quarter. Handelsbanken Fonder AB now owns 18,100 shares of the company’s stock valued at $584,000 after purchasing an additional 4,700 shares during the period. Creative Planning bought a new stake in Surgery Partners in the third quarter valued at $258,000. E. Ohman J or Asset Management AB grew its position in Surgery Partners by 31.0% in the third quarter. E. Ohman J or Asset Management AB now owns 886,088 shares of the company’s stock valued at $28,567,000 after acquiring an additional 209,888 shares during the period. Smith Group Asset Management LLC raised its stake in Surgery Partners by 48.6% during the third quarter. Smith Group Asset Management LLC now owns 16,160 shares of the company’s stock worth $521,000 after acquiring an additional 5,282 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its holdings in shares of Surgery Partners by 16.0% during the third quarter. Harbor Capital Advisors Inc. now owns 53,855 shares of the company’s stock valued at $1,736,000 after acquiring an additional 7,441 shares during the period.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SGRY. Royal Bank of Canada cut their price objective on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, November 20th. Bank of America began coverage on Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 price target for the company. JPMorgan Chase & Co. lowered their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. UBS Group initiated coverage on shares of Surgery Partners in a research note on Monday, October 14th. They set a “buy” rating and a $38.00 target price for the company. Finally, Macquarie restated an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, Surgery Partners presently has an average rating of “Moderate Buy” and an average target price of $36.56.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.